MENU
+Compare
ELVN
Stock ticker: NASDAQ
AS OF
Apr 24, 03:57 PM (EDT)
Price
$17.82
Change
+$0.05 (+0.28%)
Capitalization
880.61M

ELVN Enliven Therapeutics Forecast, Technical & Fundamental Analysis

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ELVN with price predictions
Apr 23, 2025

ELVN in upward trend: price expected to rise as it breaks its lower Bollinger Band on April 07, 2025

ELVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where ELVN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELVN's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 75 cases where ELVN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on ELVN as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ELVN just turned positive on April 22, 2025. Looking at past instances where ELVN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ELVN advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ELVN moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELVN entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.801) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ELVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ELVN is expected to report earnings to rise 8.76% to -50 cents per share on May 08

Enliven Therapeutics ELVN Stock Earnings Reports
Q1'25
Est.
$-0.50
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.14
Q1'24
Est.
$-0.54
The last earnings report on March 13 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 15.89K shares outstanding, the current market capitalization sits at 880.61M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DOXWX14.100.18
+1.29%
Dodge & Cox Global Stock X
EPSYX21.790.18
+0.83%
NYLI Epoch Global Equity Yield Class I
AVUDX7.51N/A
N/A
American Century Value R6
SMCIX18.28N/A
N/A
Shelton S&P Smallcap Index Investor
KSDVX14.60N/A
N/A
Keeley Small Cap Dividend Value A

ELVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-1.45%
ERAS - ELVN
50%
Loosely correlated
+2.90%
APGE - ELVN
49%
Loosely correlated
+2.93%
CRNX - ELVN
48%
Loosely correlated
+3.55%
DNLI - ELVN
47%
Loosely correlated
+1.85%
COGT - ELVN
47%
Loosely correlated
+3.00%
More